TM Grogan

4.3k total citations
58 papers, 3.6k citations indexed

About

TM Grogan is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, TM Grogan has authored 58 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 24 papers in Pathology and Forensic Medicine and 19 papers in Molecular Biology. Recurrent topics in TM Grogan's work include Lymphoma Diagnosis and Treatment (24 papers), Multiple Myeloma Research and Treatments (16 papers) and Glycosylation and Glycoproteins Research (13 papers). TM Grogan is often cited by papers focused on Lymphoma Diagnosis and Treatment (24 papers), Multiple Myeloma Research and Treatments (16 papers) and Glycosylation and Glycoproteins Research (13 papers). TM Grogan collaborates with scholars based in United States, Switzerland and France. TM Grogan's co-authors include TP Miller, CM Spier, WS Dalton, L Richter, SE Salmon, B W Futscher, Steve Dahlberg, M Matzner, BN Nathwani and Lippman Sm and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Analytical Biochemistry.

In The Last Decade

TM Grogan

58 papers receiving 3.5k citations

Peers

Countries citing papers authored by TM Grogan

Since Specialization

Citations

This map shows the geographic impact of TM Grogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by TM Grogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites TM Grogan more than expected).

Fields of papers citing papers by TM Grogan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by TM Grogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by TM Grogan. The network helps show where TM Grogan may publish in the future.

Co-authorship network of co-authors of TM Grogan

This figure shows the co-authorship network connecting the top 25 collaborators of TM Grogan. A scholar is included among the top collaborators of TM Grogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with TM Grogan. TM Grogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma 2010 ·Haematologica ·(unknown), Hiroaki Nitta, Wenqing Zhang, (unknown), James R. Cook, Raymond R. Tubbs, Joseph M. Unger, (unknown), Daniel O. Persky, Sarah T. Wilkinson, TM Grogan, Lisa M. Rimsza	79
2	Methods to detect P-glycoprotein and implications for other drug resistance-associated proteins 1997 ·Leukemia ·(unknown), TM Grogan	23
3	Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial 1994 ·Blood ·TP Miller, TM Grogan, Steve Dahlberg, CM Spier, RM Braziel, (unknown), Kathryn Foucar, CR Kjeldsberg, Nicolas Lévy, BN Nathwani	204
4	P-glycoprotein expression and function in circulating blood cells from normal volunteers 1994 ·Blood ·(unknown), B W Futscher, TM Grogan, WS Dalton	299
5	Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice. 1993 ·PubMed ·(unknown), (unknown), Marc Navre, TM Grogan, John M. Kittelson, Nagle Rb, Bowden Gt	174
6	Quantitative Polymerase Chain-Reaction Analysis of mdr1 mRNA in Multiple Myeloma Cell Lines and Clinical Specimens 1993 ·Analytical Biochemistry ·Bernard W. Futscher, (unknown), James H. Gerlach, TM Grogan, W. S. Dalton	61
7	P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy 1993 ·Blood ·TM Grogan, CM Spier, SE Salmon, M Matzner, James A. Rybski, (unknown), (unknown), WS Dalton	11
8	P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy 1993 ·Blood ·TM Grogan, CM Spier, SE Salmon, M Matzner, James A. Rybski, (unknown), (unknown), WS Dalton	177
9	Diffuse small cleaved-cell lymphoma: a heterogeneous disease with distinct immunobiologic subsets. 1992 ·Journal of Clinical Oncology ·Catherine P. Leith, Catherine Spier, TM Grogan, (unknown), Catherine S. Rangel, James A. Rybski, M Matzner, Thomas P. Miller	14
10	Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement [see comments] 1992 ·Blood ·(unknown), CM Spier, (unknown), TP Miller, M Matzner, TM Grogan	181
11	Multidrug-resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizer 1991 ·Blood ·SE Salmon, WS Dalton, TM Grogan, (unknown), (unknown), DJ Roe, TP Miller	195
12	Patients with localized non-Hodgkin's lymphomas provide opportunities for future research. 1991 ·PubMed ·(unknown), TM Grogan	1
13	Myelomonocytic antigen positive multiple myeloma 1989 ·Blood ·TM Grogan, BG Durie, CM Spier, L Richter, Emili Vela	74
14	Ultrastructural morphometry distinguishes Burkitt's-like lymphomas from neuroendocrine neoplasms: useful criteria applied to the evaluation of a poorly differentiated neuroendocrine neoplasm of the nasal cavity masquerading as Burkitt's-like lymphoma. 1989 ·PubMed ·(unknown), (unknown), TM Grogan, Nagle Rb, (unknown), (unknown)	5
15	Nuclear contour irregularity correlates with Leu-9-, Leu-8- cells in benign lymphoid infiltrates of skin. An ultrastructural morphometric and quantitative immunophenotypic analysis suggesting the normal T-cell counterpart to the malignant mycosis fungoides/Sézary cell. 1988 ·PubMed ·(unknown), (unknown), TM Grogan, L Richter, (unknown), (unknown), (unknown)	14
16	A comprehensive immunotopographic map of human thymus. 1988 ·Journal of Histochemistry & Cytochemistry ·Daniel P. Wirt, TM Grogan, Ray B. Nagle, (unknown), L Richter, Catherine S. Rangel, (unknown), (unknown), (unknown)	20
17	Delineation of a novel pre-B cell component in plasma cell myeloma: immunochemical, immunophenotypic, genotypic, cytologic, cell culture, and kinetic features 1987 ·Blood ·TM Grogan, BG Durie, C E Lomen, Catherine Spier, (unknown), Ray B. Nagle, Wilson Gs, L Richter, Emili Vela, (unknown)	94
18	An ultrastructural morphometric and immunophenotypic evaluation of Burkitt's and Burkitt's-like lymphomas. 1987 ·PubMed ·(unknown), TM Grogan, (unknown), (unknown), (unknown)	34
19	CALLA-positive myeloma: an aggressive subtype with poor survival 1985 ·Blood ·BG Durie, TM Grogan	3
20	Further delineation of the immunoarchitecture of the human spleen. 1984 ·PubMed ·TM Grogan, (unknown), L Richter	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact